Purchase Order 75N95018P00574
Award Date 8/30/18
Potential Completion Date 9/7/18
Potential Value $143K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation for $132,961.50. The order is for Promega's cytochrome P450 screening assay systems to support the Tox21 drug screening program. The assay kits measure the activity of various CYP enzymes, which are critical for evaluating drug metabolism and toxicity. This award was sole-sourced to Promega as the sole...
- This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company, to provide P450-Glo screening systems including CYP26A1, CYP26B1, and CYP3A4 assay kits. The $123,592.50 contract supports the Tox21 collaboration between NCATS, the National Toxicology Program, EPA, and FDA, which aims to screen thousands of compounds in vitro to develop better toxicity...
- The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $55,800 firm-fixed-price purchase order contract to Promega Corporation for the supply of P450-Glo CYP26A1 and CYP26B1 Screening Systems. This non-competitive contract, awarded without set-aside, will provide NCATS with specialized laboratory equipment and reagents to support its biomedical research and testing programs. Promega, a global life sciences company, is a...
- The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a Firm Fixed Price Purchase Order contract to Promega Corporation, a for-profit manufacturer of biological research and diagnostic products. The $66,970.35 contract is for the delivery of Promega's proprietary laboratory equipment, reagents, and consumables to support the agency's biomedical research and testing programs. This award is under a $10 million...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...
- Promega Corporation received a contract award valued at $21,260 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, on April 12, 2016. This firm fixed-price BPA (Blanket Purchase Agreement) call was issued without small business set-aside designation and required performance in Madison, Wisconsin, with completion by February 28, 2017. The contract procures specialized kinase assay products including ADP-Glo Kinase Assay kits...
- This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,294.20 firm fixed price purchase order to Promega Corporation for CASPASE-GLO(R) 3/7 ASSAY, 100ML. The contract has a completion date of September 8, 2023 and was awarded on August 18, 2023. This order is not associated with a set-aside program. Promega Corporation is a global life sciences company that provides various biological research and diagnostic...
- This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Promega Corporation for 100,000 units of the ADP-GLO Kinase Assay (Promega Product #V9103) with a potential value of $17,990.25. The contract has a performance period running through September 30, 2024. Promega is a global life sciences company that provides DNA analysis equipment, reagents, assays, and...
- This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...